PHV-wordings
HMG-CoA reductase inhibitors (statins) - correction
PRAC signal recommendation
|
10/02/2023
Risk for Myasthenia gravis. Further information and the changes to the product information in all EU languages are available on the EMA website.
Methotrexate
PSUFU
|
03/02/2023
Further information is available on the HMA-Website.
Methoxyflurane
PSUR-outcome
|
02/02/2023
Further information and amendments to the product information in all EU languages are available on the EMA website.
Bleomycin
PSUR-outcome
|
02/02/2023
Further information and amendments to the product information in all EU languages are available on the EMA website.
Fentanyl (transdermal patches, solution for injection)
PSUR-outcome
|
31/01/2023
Further information and amendments to the product information in all EU languages are available on the EMA website.
Omeprazole
PSUR-outcome
|
30/01/2023
Further information and amendments to the product information in all EU languages are available on the EMA website.
Vinorelbine
PSUR-outcome
|
30/01/2023
Further information and amendments to the product information in all EU languages are available on the EMA website.
Triptorelin
PSUR-outcome
|
30/01/2023
Further information and amendments to the product information in all EU languages are available on the EMA website.
Amfepramone
Referral
|
19/01/2023
Further information can be found in the Commission Decision and its annexes, which are available in all EU languages on the European Commission's (EC) website.
Amoxicillin / Clavulanate
PSUR-outcome
|
17/01/2023
Further information and amendments to the product information in all EU languages are available on the EMA website.